Home
About
Overview
Sharing Data
ORCID
Help
History (44)
Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer.
Review of clinic trials: agents targeting c-Met.
Factors influencing subspecialty choice among radiology residents: a case study of pediatric radiology.
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer.
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
See All 44 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics. Mass Spectrom Rev. 2007 May-Jun; 26(3):451-66.
View in:
PubMed
subject areas
Biomarkers, Tumor
Diagnosis, Computer-Assisted
Forecasting
Lung Neoplasms
Mass Spectrometry
Neoplasm Proteins
Proteome
Proteomics
authors with profiles
Ravi Salgia